Go-to-market & Reimbursement Pathways in Medtech and Digital Health
🔎 Overview
Bringing a MedTech or digital health product to market requires navigating complex commercialization and reimbursement systems. This session offers a clear, high-level roadmap—covering product development, regulatory considerations, payer expectations, and a comparison of U.S. (70%) and Canadian (30%) pathways—to help you accelerate market success and strengthen valuation.
🎯 What You’ll Learn
Key commercialization pathways from feasibility ➜ development ➜ quality management ➜ clinical validation
Reimbursement models across devices, diagnostics, consumables, connected products, and Class I–IV categories
U.S. vs. Canada: billing, funding, regulatory differences, and how to approach each market
Payer types, behaviours, and expectations that shape coverage and revenue
How strategic reimbursement planning enhances valuation
Common sector challenges—and how companies successfully overcome them
🎤 Speaker: Dheeman Vaidya
Global Business Development, Strategic Marketing & Regulatory Strategy Leader – MedTech, IVD & Digital Health
An award-winning leader with deep expertise across MedTech, diagnostics, digital health, and pharmaceuticals. Dheeman specializes in business development, market access, regulatory strategy, commercial excellence, and strategic marketing.
He currently leads IQVIA Canada’s MedTech business development, supporting companies with commercialization, regulatory needs, digital marketing, market access, technology, and compliance solutions. Passionate about AI, sensor-based tech, robotics, and miniaturized medical devices.
📅 Event Details
Date: December 8
Time: 2:00–3:30 PM EST
Location: Zoom
👥 Who Should Attend
Ideal for:
MedTech & digital health founders and innovators
Product, regulatory, or market access professionals
Researchers, students, and professionals exploring commercialization
This webinar is a joint initiative between the Biomedical Zone, Ontario Genomics, and BioCreate.
RSVP now to secure your spot!